T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma
Van Abel KM., et al.
September 2020
Authors and Affiliates
Kathryn M Van Abel 1, David M Routman 2, Eric J Moore 3, Daniel J Ma 2, Linda X Yin 3, Paul A Fields 4, Matt Schofield 4, Kathleen R Bartemes 3, Kyriakos Chatzopoulos 5, Daniel L Price 3, Jeffrey R Janus 3, Jan L Kasperbauer 3, Katharine A Price 6, Ashish V Chintakuntlawar 6, Michelle A Neben-Wittich 2, Robert L Foote 2, Joaquin J Garcia 5;
1 Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: vanabel.kathryn@mayo.edu.
2 Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
3 Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN 55905, USA.
4 Adaptive Biotechnologies, Seattle, WA 98102, USA; Department of Pathology and Clinical Medicine, Mayo Clinic, Rochester, MN 55905, USA.
5 Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN 55905, USA.
6 Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.